Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model) [PDF]
Pathogens, 2015 Chikungunya virus (CHIKV) is a positive-sense RNA virus transmitted by Aedes mosquitoes. CHIKV is a reemerging Alphavirus that causes acute febrile illness and severe and debilitating polyarthralgia of the peripheral joints. Huge epidemics and the rapid spread of CHIKV seen in India and the Indian Ocean region established CHIKV as a global health ...
Rebecca Broeckel +3 more
openaire +5 more sources
LABORATORY INVESTIGATION OF CHIKUNGUNYA OUTBREAK IN PERAK FROM 2019 TO 2020
International Journal of Infectious Diseases, 2023 Intro: Chikungunya virus (CHIKV) is a vector-borne virus which is transmitted primarily by Aedes aegypti and Aedes albopictus. A period between 2016 to 2020, chikungunya outbreaks were reported in several Asian countries. In Perak, Malaysia, there was an
Y.Z. Lim
doaj +1 more source
A Mouse Model for Studying Post-Acute Arthritis of Chikungunya
Microorganisms, 2021 Chikungunya virus (CHIKV) was introduced to the Americas in 2013, causing two million infections across over thirty countries. CHIKV causes a chronic debilitating arthritis in one fourth of infected individuals and currently evidence-based targeted ...
Aileen Y. Chang +9 more
doaj +1 more source
Chikungunya virus (CHIKV) infection: Analytical performance of real-time NASBA assay [PDF]
International Journal of Infectious Diseases, 2010 n ...
G. Rossini +5 more
openaire +2 more sources
Genome-Wide Approaches to Unravel the Host Factors Involved in Chikungunya Virus Replication
Frontiers in Microbiology, 2022 Chikungunya virus (CHIKV), the causative agent of Chikungunya fever (CHIKVF) that is often characterized by fever, headache, rash, and arthralgia, is transmitted to humans by Aedes mosquito bites.
Atsushi Tanaka, Youichi Suzuki
doaj +1 more source
Treatment of Chikungunya Virus (CHIKV) Using Targeted Immunotherapy
, 2022 Chikungunya virus (CHIKV) is the most common mosquito-borne Alphavirus infecting humans worldwide. Up to date, there are no antiviral treatments or vaccines approved to treat or prevent CHIKV for which treatments remain symptomatic based on clinical manifestations.
Nsole, Biteghe, Fleury Augustin +5 more
openaire +3 more sources
Mathematical analysis and control of chikungunya (CHIKV) virus by SEIR model
International journal of health sciences, 2022 Chikungunya is a re-emerging arboviral disease in Asia and Africa infected by Aedes mosquitoes which had posed a global threat in several countries. Vector borne diseases are the primary cause of death in most of the world countries, hence it becomes pertinent to control these vector borne diseases.
Seema Singla, Madhuchanda Rakshit
openaire +1 more source
Chikungunya as a cause of acute febrile illness in southern Sri Lanka. [PDF]
PLoS ONE, 2013 Chikungunya virus (CHIKV) re-emerged in Sri Lanka in late 2006 after a 40-year hiatus. We sought to identify and characterize acute chikungunya infection (CHIK) in patients presenting with acute undifferentiated febrile illness in unstudied rural and ...
Megan E Reller +13 more
doaj +1 more source
Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in Mice
Viruses, 2023 Chikungunya virus (CHIKV) is a mosquito-transmitted pathogen that causes chikungunya disease (CHIK); the disease is characterized by fever, muscle ache, rash, and arthralgia.
Douglas Barker +9 more
doaj +1 more source
Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine [PDF]
The Journal of Infectious Diseases, 2019 Abstract Background Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes severe flu-like symptoms. The acute symptoms disappear after 1 week, but chronic arthralgia can persist for years.
Lisa Henss +7 more
openaire +3 more sources